The two most significantly enriched pathways and the involved differentially expressed genes (DEG).

aSCD5  =  stearoyl-CoA desaturase 5; GLG1  =  golgi glycoprotein 1; ELOVL6  =  ELOVL family member 6; PTPLB  =  protein tyrosine phosphatase-like B; ACAA1  =  acetyl-CoA acyltransferase 1; PECR  =  privacy and electronic communications regulations; MFSD4  =  major facilitator superfamily domain containing 4; DLEC1  =  deleted in lung and esophageal cancer 1; PTPLAD1  =  protein tyrosine phosphatase-like A domain containing 1; HSDL1  =  hydroxysteroid dehydrogenase like gene; LOC423119  =  Gallus gallus fatty acid desaturase 1-like; LPL  =  lipoprotein lipase; PNPLA2  =  patatin-like phospholipase domain containing 2; PPAP2A  =  phosphatidic acid phosphatase 2A; PPAP2B  =  phosphatidic acid phosphatase 2B; AGPAT6  =  1-acylglycerol-3-phosphate O-acyltransferase 6; SHROOM3  =  shroom family member 3; ALDH7A1  =  aldehyde dehydrogenase 7 family, member A1; AKR1B10  =  aldo-keto reductase family 1, member B10; DGKD  =  diacylglycerol kinase; GK5  =  glycerol kinase 5; GLA  =  galactosidase, alpha; MOGAT1  =  monoacylglycerol O-acyltransferase 1; AR  =  androgen receptor; LIPG  =  endothelial lipase.
The two most significantly enriched pathways and the involved differentially expressed genes (DEG).